{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20051220",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "15887",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021629s001,002lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20040416",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "37352",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021629lbl.pdf",
              "date": "20200323",
              "type": "Label"
            },
            {
              "id": "42239",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-629_Apidra.html",
              "date": "20200323",
              "type": "Review"
            },
            {
              "id": "53296",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/021629s015_Insulin Glulisine (Apidra)_Statistics_PREA.pdf",
              "date": "20200323",
              "type": "Pediatric Statistical Review"
            },
            {
              "id": "53297",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/021629s015_Insulin Glulisine (Apidra) (NO-AP-LBL)_Clinpharm_PREA.pdf",
              "date": "20200323",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "53298",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/021629s015_Insulin Glulisine (Apidra)_Clinical_PREA.pdf",
              "date": "20200323",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "5877",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21629ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "28",
          "submission_status": "AP",
          "submission_status_date": "20130906",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "37355",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021629Orig1s028ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "28265",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021629s028lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "42",
          "submission_status": "AP",
          "submission_status_date": "20221130",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "72758",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/021629Orig1s042ltr.pdf",
              "date": "20221201",
              "type": "Letter"
            },
            {
              "id": "72778",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021629s042lbl.pdf",
              "date": "20221205",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "26",
          "submission_status": "AP",
          "submission_status_date": "20130605",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "40",
          "submission_status": "AP",
          "submission_status_date": "20191115",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "60911",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021081Orig1s073, s074; 021629Orig1s039, s040; 206538Orig1s013, s014ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "60965",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021081Orig1s073, s074; 021629Orig1s039, s040; 206538Orig1s013, s014ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "24",
          "submission_status": "AP",
          "submission_status_date": "20130722",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "30",
          "submission_status": "AP",
          "submission_status_date": "20150225",
          "review_priority": "901 REQUIRED",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "37356",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021629Orig1s030ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "28266",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021629s030lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20090224",
          "review_priority": "N/A",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "42240",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021629s008ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "5878",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/021629Orig1s008.pdf",
              "date": "20200323",
              "type": "Review"
            },
            {
              "id": "15888",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021629s008lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "10",
          "submission_status": "AP",
          "submission_status_date": "20070412",
          "review_priority": "UNKNOWN",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "15889",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021629s010ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "28264",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021629s010lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "39",
          "submission_status": "AP",
          "submission_status_date": "20191115",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "60910",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021081Orig1s073, s074; 021629Orig1s039, s040; 206538Orig1s013, s014ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "60966",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021629s039s040lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20051220",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "37353",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021629s001,002lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "37",
          "submission_status": "AP",
          "submission_status_date": "20181220",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "56972",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021629s037s038lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "29",
          "submission_status": "AP",
          "submission_status_date": "20140514",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "5880",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021629s029lbl.pdf",
              "date": "20200323",
              "type": "Label"
            },
            {
              "id": "15890",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021629Orig1s029ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "27",
          "submission_status": "AP",
          "submission_status_date": "20130215",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "31",
          "submission_status": "AP",
          "submission_status_date": "20150303",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "15",
          "submission_status": "AP",
          "submission_status_date": "20081024",
          "review_priority": "UNKNOWN",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "5879",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021629s015lbl.pdf",
              "date": "20200323",
              "type": "Label"
            },
            {
              "id": "37354",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021629s015ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "38",
          "submission_status": "AP",
          "submission_status_date": "20181220",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "56973",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021629s037s038lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "BLA021629",
      "sponsor_name": "SANOFI AVENTIS US",
      "openfda": {
        "application_number": [
          "BLA021629"
        ],
        "brand_name": [
          "APIDRA",
          "APIDRA SOLOSTAR"
        ],
        "generic_name": [
          "INSULIN GLULISINE"
        ],
        "manufacturer_name": [
          "sanofi-aventis U.S. LLC"
        ],
        "product_ndc": [
          "0088-2500",
          "0088-2502"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS",
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "INSULIN GLULISINE"
        ],
        "rxcui": [
          "485210",
          "803194",
          "847259",
          "847261"
        ],
        "spl_id": [
          "6be54063-6912-4810-b1c7-dfca969224d8"
        ],
        "spl_set_id": [
          "e7af6a7a-8046-4fb4-9979-4ec4230b23aa"
        ],
        "package_ndc": [
          "0088-2500-33",
          "0088-2500-34",
          "0088-2502-00",
          "0088-2502-05",
          "0088-2502-01"
        ],
        "nui": [
          "N0000004931",
          "N0000175453"
        ],
        "pharm_class_cs": [
          "Insulin [Chemical/Ingredient]"
        ],
        "pharm_class_epc": [
          "Insulin Analog [EPC]"
        ],
        "unii": [
          "7XIY785AZD"
        ]
      },
      "products": [
        {
          "product_number": "003",
          "reference_drug": "No",
          "brand_name": "APIDRA SOLOSTAR",
          "active_ingredients": [
            {
              "name": "INSULIN GLULISINE RECOMBINANT",
              "strength": "300 UNITS/3ML"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "APIDRA",
          "active_ingredients": [
            {
              "name": "INSULIN GLULISINE RECOMBINANT",
              "strength": "1000 UNITS/10ML (100 UNITS/ML)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INTRAVENOUS, SUBCUTANEOUS",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "APIDRA",
          "active_ingredients": [
            {
              "name": "INSULIN GLULISINE RECOMBINANT",
              "strength": "300 UNITS/3ML (100 UNITS/ML)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INTRAVENOUS, SUBCUTANEOUS",
          "marketing_status": "Discontinued"
        }
      ]
    }
  ]
}